Contents
Download PDF
pdf Download XML
975 Views
119 Downloads
Share this article
Research Article | Volume 13 Issue:1 (, 2023) | Pages 1319 - 1319
A Study to Assess Red Cell Index (Rci) As a Marker for Severity of Chronic Obstructive Pulmonary Disease (Copd)
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
March 30, 2023
Abstract

Introduction: Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnoea, cough, sputum production, exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. Aim: To study RCI as a marker for severity of COPD. Material and Methods: An observational study was conducted in Department of Pulmonary Medicine, K. N. Chest hospital, after approval from institution ethical committee, Dr. S. N. Medical College, Jodhpur. Result: In our study, 58 (58.0%) patients were Cigarettes, 36 (36.0%) patients were Ex-smoker and 6 (6.0%) patients were Non-Smoker. Conclusion: We conclude that, majority numbers of patients were Cigarettes in Stage 1 compared to Stage 2, Stage 3 and Stage 4 though it was not statistically significant.

Keywords
Recommended Articles
Research Article
Clinical Profile and Etiological Evaluation of Dysphagia in Patients Attending an ENT Outpatient Department of a Tertiary Care Teaching Hospital
Published: 15/06/2020
Download PDF
Research Article
Incidence, Microbiological Profile, and Risk Factors for Surgical Site Infection Following Major Abdominal Surgery: A Prospective Observational Study
...
Published: 16/03/2024
Download PDF
Research Article
Clinical Profile and Management of Complications of Chronic Otitis Media: A Prospective Study in a Tertiary Care Centre
Published: 18/04/2020
Download PDF
Research Article
Clinicopathological Profile of Anemia in Pregnant Women: A Hospital-Based Study
Published: 10/12/2024
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.